Did You Know...
...that the first rickshaw was invented in 1869 by an American Baptist minister, the Rev. E. Jonathan Scobie, to transport his invalid wife around the streets of Yokohama?
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7892574 | Topical administration of oxazolidinones for transdermal delivery Disclosed is a method of treating a non-topical infection selected from the group consisting of ear infections, skin and soft tissue infections, acne, infected wounds, bacteremia, in a useful warm blooded mammal who is in need of such treatment which comprises topic... | 02/22/2011 |
| 7081249 | Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma c... | 07/25/2006 |
| 7081251 | Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma c... | 07/25/2006 |
| 7081250 | Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma c... | 07/25/2006 |
| 7081252 | Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma c... | 07/25/2006 |
| 7074425 | Hemostatic compositions and methods The present invention provides methods and compositions involving resorbable hemostatic agents that have the essential absence of microfibrillar collagen. Resorbable hemostatic agents of the present invention comprise polyethylene glycol, which controls bleeding in ... | 07/11/2006 |
| 7071235 | Latent reactive blood compatible agents A reagent and related method for use in passivating a biomaterial surface, the reagent including a latent reactive group and a bifunctional aliphatic acid (e.g., fatty acid), in combination with a spacer group linking the latent reactive group to the aliphatic acid ... | 07/04/2006 |
| 7045145 | Transdermal contraceptive delivery system and process A transdermal contraceptive delivery system (TCDS) for fertility control in women is described. It comprises a backing layer, an adjoining layer of a solid absorption adhesive polymer matrix in which effective daily doses of an estrogen and a progestin are dispersed... | 05/16/2006 |
| 7029694 | Compositions and methods for transdermal oxybutynin therapy The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma c... | 04/18/2006 |
| 7018647 | Patches for external use In order to provide an external skin patch having improved painkilling effect for pains accompanied by inflammation, such as chronic arthrorheumatism, arthrosis deformans or low back pain, an external skin patch is obtained by coating a drug-containing base on a sub... | 03/28/2006 |
| 7018649 | Felodipine transdermal device and methods A method of effectively treating hypertension in humans is achieved by administering felodipine via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24... | 03/28/2006 |
| 7014860 | Hyaluronic acid gel, process for producing the same, and medical material containing the same Production of a hyaluronic acid gel, which comprises keeping hyaluronic acid in water at a hyaluronic acid concentration of at least 5 wt % in the presence of an acid component in an amount at least equimolar with the carboxyl groups in the hyaluronic acid. ... | 03/21/2006 |
| 7011843 | Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system A method for the protection of a human being against any health impairment as a result of the ingestion of the whole or parts of a transdermal therapeutic system containing at least one pharmacologically active ingredient, which is toxic or induces nausea or addicti... | 03/14/2006 |
| 7001613 | Skin friendly active substance patch for transdermal administration of hyperemic active substances An active substance matrix patch for controlled delivery of at least one hyperemic active substance to the skin, comprising a flexible cover layer and a water insoluble, pressure sensitive adhesive active substance matrix, wherein said adhesive matrix is free from m... | 02/21/2006 |
| 6994869 | Nasogastric enteral formulations The present invention relates to a nasogastric formulation comprising an amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond hydrolysable in the colon to deliver free fatty acids such as short c... | 02/07/2006 |
| 6986908 | Delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite The present invention relates to a composition containing a δ-aminolevulinic acid as effective dose for prevention and treatment of infection by pathogenic microorganisms and parasite. More particularly, it refers to the composition for prevention and treatment thr... | 01/17/2006 |
| 6974588 | Transdermal patch for delivering volatile liquid drugs A transdermal patch for administering a volatile liquid drug, such as nicotine, transdermally to a patient comprising a four-layer laminated composite of: a top drug impermeable backing layer; a pressure sensitive silicone adhesive layer containing the drug; a press... | 12/13/2005 |
| 6964781 | Sustained release drug delivery devices with prefabricated permeable plugs The present invention is directed to an improved sustained release drug delivery device comprising a drug core, a unitary cup, and a prefabricated permeable plug. ... | 11/15/2005 |
| 6962715 | Method and dosage form for dispensing a bioactive substance A method of manufacturing a bioactive fluid dose on an ingestible sheet, comprising the steps of advancing the ingestible sheet to a dispense position, and activating a fluid ejector to dispense essentially a drop of a bioactive fluid onto the ingestible sheet. ... | 11/08/2005 |
| 6942875 | Adhesive treatment for skin yeast infections A method of treating or preventing skin yeast infections, such as cutaneous candidiasis, includes applying a polymerizable monomer adhesive composition to an area of skin afflicted with or susceptible to a skin yeast infection, optionally with at least one of an add... | 09/13/2005 |
| 6926904 | Cosmetic product with proof device A cosmetic product system is provided which includes a cosmetic composition for combating signs of aging, and a test device packaged with the composition. The device includes a mechanism for evaluating progress of the combat against the signs of aging occurring over... | 08/09/2005 |
| 6923982 | Calendered hydrocolloid dressing A calendered hydrocolloid dressing for the wound care and a one step method of manufacturing the hydrocolloidal dressing are described. In particular, the invention is concerned with a hydrocolloid dressing which is absorbent, non-damaging to the skin and comfortabl... | 08/02/2005 |
| 6913766 | Preparation consisting of a film, sheet or wafer-shaped form of administration with a two-layered structure and an integrated identification marking A sheet-like, film-like or wafer-like preparation for administering substances affecting flavor or odor and/or substances for care and/or curative substances, comprising a coding of these substances in the form of characters and/or graphic symbols or patterns, with ... | 07/05/2005 |
| 6902740 | Pyrrolidonoethyl (meth)acrylate containing pressure sensitive adhesive compositions The present invention relates to a pressure sensitive adhesive composition comprising a copolymer comprising pyrrolidonoethyl acrylate or pyrrolidonoethyl methacrylate. This composition may be used as part of a transdermal drug delivery device. ... | 06/07/2005 |
| 6902741 | Laminates containing an active substance transdermal system The transdermal system includes a sex hormone-containing adhesive matrix, which contains inclusions of a sex hormone in a hydrophilic non-crosslinked polymer in dissolved or dispersed form. The inclusions have a concentration of 20 to 90 percent by weight of the sex... | 06/07/2005 |
| 6899894 | Transdermal therapeutic system containing hormones and crystallization inhibitors A transdermal therapeutic system in plaster form for controlled release of oestradiol in combination with norethisterone acetate, comprising a backing layer, a reservoir supersaturated with active ingredients which is attached to said backing layer and prepared usin... | 05/31/2005 |
| 6893656 | Athletic patch The present invention relates to patches for the administration of an athletic supplement to subjects engaged in rigorous exercise or heavy outdoor work. The invention also relates to methods of administering nutrients to subjects using the patch of the invention. | 05/17/2005 |
| 6893655 | Transdermal delivery devices A transdermal delivery device including at least one pressure sensitive adhesive layer having a first major surface and a second major surface, wherein at least one of the first and second major surfaces is a structured surface; a cap layer in contact with the struc... | 05/17/2005 |
| 6890551 | Light occlusive patch Occlusive plaster consisting of at least one layer of a foam material which is provided on the lower side with a skin-compatible self-adhesive layer. ... | 05/10/2005 |
| 6890552 | Manufacturing therapeutic enclosures Devices and methods for enhancing the healing of wounds, especially chronic wounds (e.g., diabetic wounds), involving the use of keratinocytes are described. Keratinocytes are grown on a transplantable solid support (e.g., collagen-coated beads), and the keratinocyt... | 05/10/2005 |
| 6887494 | Pigments and extender pigments with enhanced skin adhesion for cosmetic preparations A composition and method for enhancing skin adhesion of cosmetics by using pigments and extender pigments for the cosmetics, which pigments and extender pigments are treated with at least one hydrophobidizing agent and/or hydrophobidizing/lipophobidizing agent and o... | 05/03/2005 |
| 6884434 | Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof A transdermal therapeutic system, comprising a backing layer inert to the components of the matrix, a self-adhesive matrix layer containing (−)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol in an effective amount and a protective foil or s... | 04/26/2005 |
| 6884427 | Filamentary means for introducing agents into tissue of a living host The present invention provides a filamentary structure for the introduction of agents into a living host, comprising a filament comprising a solid core and a porous sheath which coats at least a portion of the solid core. When the filamentary structure is to be perm... | 04/26/2005 |
| 6878385 | Wrinkle-resistant dressing and gently adhesive composition thereof A dressing for preventing and treating blisters and for treating corns, calluses, warts, and other skin conditions. The dressing has a dressing layer covered by protective cover layer and a release sheet. The dressing has an adhesive composition on a skin-contacting... | 04/12/2005 |
| 6875444 | Wrinkle indicator tape strip A test kit and method for visualizing fine lines and wrinkles is provided, the kit including a transparent strip with an adhesive on one surface thereof and an imaging substrate with at least one darkened glossy area for receiving the transparent strip. Written inst... | 04/05/2005 |
| 6872407 | Extended release formulations of erythromycin derivatives Disclosed is a pharmaceutical composition for extended release of an erythromycin derivative in the gastrointestinal environment. The composition comprises an erythromycin derivative and a pharmaceutically acceptable polymer so that, when ingested orally, the compos... | 03/29/2005 |
| 6866857 | Oxalipatinum preparation packaging Flexible impervious bag for medical use containing a pharmaceutical preparation of liquid oxaliplatinum said flexible bag is constructed from plastic materials, with the proviso that any portion to the bag in direct contact with said pharmaceutical preparation of li... | 03/15/2005 |
| 6861067 | Hydrogel wound dressing and the method of making and using the same A hydrogel wound dressing which is highly absorptive, contours to a wound site, and maintains the wound in a moist state to promote healing thereof. The hydrogel wound dressing may also contain additives to prevent bacterial and fungal infections and to control woun... | 03/01/2005 |
| 6855326 | Skin protection composition The invention relates to cationic compounds and triester compounds to be used for preparation of compositions, which preferably can be in the form of lotions, creams, powders, oils, foams and the like, and be applied to the skin to prevent or reduce or treat skin ra... | 02/15/2005 |
| 6844007 | Plaster containing felbinac A plaster comprising a styrene-isoprene-styrene block copolymer 10-40 wt %, a rosin-based resin 5-30 wt %, a plasticizer 20-70 wt %, polyisobutylene 6-40 wt %, an antioxidant 0.1-5 wt %, and felbinac as a medicinally effective component 1.1-10 wt %, wherein the plas... | 01/18/2005 |
